Morgan Stanley upgraded price targets for three ASX mid-caps earlier this week, citing untapped growth opportunities that could deliver substantial returns for investors willing to look beyond current market valuations.
The investment bank raised its price targets for:
Life360 (ASX: 360): Retained Overweight, target up to $40 from $33.30
Temple & Webster (ASX: TPW): Retained Overweight, target up to $28 from $18.50
Eagers Automotive (ASX: APE): Retained Overweight, target up to $20 from $17.00
Each company possesses what Morgan Stanley calls "mispriced optionality" - growth opportunities not fully reflected in current market expectations or analyst forecasts.
For Life360, the location-tracking app company, the key lies in expanding its subscription base through pet tracking services. The feature represents a natural extension of the company's core family safety platform and could significantly boost recurring revenue.
Temple & Webster, Australia's largest online furniture retailer, has potential to expand beyond its core business into the broader home improvement market. This diversification could tap into a much larger addressable market and extend the company's growth runway.
Eagers Automotive, one of Australia's largest automotive retailers, could benefit from opportunities in the fixed-price used car market. This segment offers higher margins and more predictable pricing than traditional used car sales.
The analysts say that all three companies have management teams with proven ability to identify and execute on new growth opportunities. Each has historically delivered results ahead of market expectations, with leadership teams that have significant skin in the game.
Life360 has a track record of smashing analyst earnings expectations, sending the stock to fresh all-time highs. Notable earnings beats include its 1Q25 result (13-May-25, shares up 15%) and the FY23 result (1-Mar-24, shares up 40%)
Temple & Webster shares have rallied an average ~14% in the last three reporting seasons, with the latest 1H25 results (13-Feb) delivering 117.2% net profit growth to $9.0 million or 76% ahead of market expectations
Eagers Automotive has emerged as one of the top performing ASX 200 stocks, up 38% year-to-date. It surged 20% during its latest 1H25 result (27-Feb) as its earnings materially outperformed sector peers.
"We love to back great management teams running competitively advantaged businesses," Morgan Stanley analysts noted. "In our combined 40 years of covering small and mid-cap stocks, we find that this combination tends to over-deliver on unexpected growth."
Despite the bullish outlook, Morgan Stanley acknowledges significant risks. All three stocks have performed strongly this year, with much of the gains coming from improved valuations rather than just higher earnings expectations.
Life360 is up 41% year-to-date and up 102% in the past twelve months, trading near record levels
Eagers Automotive is also up 41% year-to-date and trading near record levels
Temple & Webster is up 64% year-to-date and up as much as 83% earlier this month, also trading near record levels
The analysts warn that each company has experienced material devaluations in the past, and similar selloffs could occur again. Their bear case scenarios show "significant downside" potential. However, the investment bank believes the probability of success for each growth initiative outweighs the risks, making the current risk-reward profile attractive for investors.
Morgan Stanley's analysis focuses on the companies' potential to create substantially more value than they currently capture from their markets. The bank sees these businesses as operating well below their optimised potential, with capacity to significantly scale operations without proportional increases in costs.
The upgraded price targets include both bullish and bearish scenarios, with the analysts estimating potential earnings upside of 30-60% versus their base case estimates if the growth initiatives succeed.
For investors, these stocks represent a bet on management teams' ability to expand beyond their current markets and capture larger shares of adjacent opportunities - a strategy that has historically rewarded patient shareholders in the Australian mid-cap space.
Get the latest news and insights direct to your inbox